Location: Home
  • search
  • go
  • Relate News
  • 7/14/2016China's Supreme Court And Supreme Procuratorate Issue Interpretation o...
  • 7/14/2016China Issues Guidance Clarifying Core Tasks and Deadlines for Applicat...
  • 7/14/2016Chinese API Industry Revenue Expected to Grow at 9.5% GAGR 2016-2020
  • 7/13/2016EY: The Rise of Private Health Insurance in China
  • 7/13/2016MIIT Reports Chinese Pharma Industry Performance in 2015
  • 7/13/201680% Listed Chinese Pharma Cos Forecast Positive Earnings in H1/2016
  • 7/13/2016CFDA Publishes 2015 Annual Report for Adverse Drug Reaction Monitoring
  • 7/12/2016Pfizer to Use GE's Mobile Biotech Factory to Make Next-Generation Drug...
  • 7/12/2016CFDA Regulation for Registration of Special Medical Purpose Foods Went...
  • 7/12/2016Pharmaceutical Trademark Protection in China
  • 7/12/2016GE: There Is a Huge Unmet Need for Affordable Biologics in China
  • 7/12/2016CFDA to Initiate New Round of Clinical Data Inspection with MNCs in th...
  • 7/12/2016Sanming City Establishes Medical Insurance Bureau
  • 7/12/2016China Expands Cancer Data Collection Efforts as Part of Big Data Plan
  • 7/12/2016Four Chinese Pharma Industry Associations Sign MOU over MR Standards
  • 7/11/2016Huapont, Angionetics Enter Agreement for PE Investment and Development...
  • 7/10/2016CFDA Vice Minister Wu Zhen meets Japanese Pharma and Medical Device De...
  • 7/9/2016Novartis Sharply Reduces Price of Lucentis
  • 7/9/2016SAIC Issues Internet Advertising Rules, Limiting Medical and Drug Ads
  • 7/9/2016Novartis's China R&D Center to Focus on Locally Prevalent Diseases
  • 7/9/2016Ali Health Relaunches New Tracking System in China
  • 7/9/2016Can Big Data Cure China's Health Woes?
  • 7/9/2016Building A Translational Medicine Powerhouse in China
  • 7/9/2016CPhI Report Optimistic About Outlook of Chinese Pharma
  • 7/9/2016USFDA Issues Warning Letters to Shanghai Desano and Chongqing Lummy
  • 7/9/2016USFDA Cites Guangzhou Haishi BioTech with CGMP Violations
  • 7/9/2016Allergan Eyes Opportunities in China and Rest of Asia
  • 7/9/2016Alibaba Health Re-engineers Business After Setbacks
  • 7/9/2016LSE Health/State Council Report Outlines China's Pharma Sector Reform ...
  • 7/7/2016Shenzhen Launches Its Own Hospital Drug GPO Platform
  • Page:418/798 Total number of articles:23912: [First][<<] [416] [417] [418] [419] [420] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group